Cefotaxime and Rash vesicular - a phase IV clinical study of FDA data

Summary:

Rash vesicular is reported as a side effect among people who take Cefotaxime (cefotaxime sodium), especially for people who are male, 20-29 old, have been taking the drug for 1 - 6 months also take Vancomycin, and have Embolism.

The phase IV clinical study analyzes which people have Rash vesicular when taking Cefotaxime. It is created by eHealthMe based on reports of 7,540 people who have side effects when taking Cefotaxime from the FDA, and is updated regularly.

What is Cefotaxime?

Cefotaxime has active ingredients of cefotaxime sodium. eHealthMe is studying from 7,559 Cefotaxime users. Check the latest studies of Cefotaxime.

What is Rash vesicular?

Rash vesicular (rash with a small bubble) is found to be associated with 526 drugs and 644 conditions by eHealthMe. Check the latest studies of Rash vesicular.

On Jul, 15, 2026

7,540 people reported to have side effects when taking Cefotaxime.
Among them, 15 people (0.2%) have Rash vesicular.

Among these 15 people:

How long have people been on Cefotaxime when they have Rash vesicular? *

What is the gender of people who have Rash vesicular when taking Cefotaxime? *

female: 7.14 %
male: 92.86 %

What is the age of people who have Rash vesicular when taking Cefotaxime? *

What are other drugs people take besides Cefotaxime? *

Vancomycin: 8 people, 53.33%
Xarelto: 6 people, 40.00%
Cefazolin: 5 people, 33.33%
Xylocaine: 3 people, 20.00%
Ramipril: 3 people, 20.00%
Ketoprofen: 3 people, 20.00%
Leucovorin Calcium: 3 people, 20.00%
Lovenox: 3 people, 20.00%
Melatonin: 3 people, 20.00%
Midazolam Hydrochloride: 3 people, 20.00%

What are other side effects people have besides Rash vesicular? *

Eosinophilia (eosinophil count in the peripheral blood exceeds): 9 people, 60.00%
Purpura (purplish discoloration of the skin): 8 people, 53.33%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 8 people, 53.33%
Inflammation: 8 people, 53.33%
Transaminases Increased: 6 people, 40.00%
Fever: 4 people, 26.67%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 4 people, 26.67%
Dyspnea (difficult or laboured breathing): 4 people, 26.67%
Septic Shock (shock due to blood infection): 4 people, 26.67%
Laryngeal Discomfort: 3 people, 20.00%

What are the existing conditions these people have? *

Osteomyelitis (infection of bone): 8 people, 53.33%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 8 people, 53.33%
Headache (pain in head): 3 people, 20.00%
Device Occlusion: 1 person, 6.67%
Cough: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cefotaxime and have Rash vesicular?

- Check whether Rash vesicular is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefotaxime:

Cefotaxime (7,559 reports)

Rash vesicular treatments and more:

Rash vesicular (5,254 reports)

Browse all side effects of Cefotaxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash vesicular:

Rash vesicular (527 drugs)

Browse all the conditions that are associated with Rash vesicular:

Rash vesicular (644 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefotaxime sodium (the active ingredients of Cefotaxime) and Cefotaxime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.